Tetsuya Katada

Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.

Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors.

Inter-American Development Bank engages in the provision of development financing to the Latin American and the Caribbean region. Its activities include provision of loans, grants, and technical assistance; and conducts extensive research. It provides services to the central governments, provinces, municipalities, private firms, and non-governmental organizations. The company was founded in 1959 and is headquartered in Washington, DC.

Fujikyu Corp. engages in the sales of handicraft and household goods. Its products include yarn, fabrics, dressmaking apparels, and other clothing and household products. It operates through the following business divisions: Store Sales, Mail Order, and Others. The Store Sales division handles the operation of handicraft specialty stores such as Craft Heart Tokai, Craft World, Craft Park, and Craft Loop; and household goods specialty stores such as st-toremu. The Mail Order division manages online product sales offered in Craft Heart Tokai.com. It also deals with the product sales in Rakuten, Yahoo Store, and Amazon Store that offers products from st-toremu, shugale, and Just Partner. The Others division includes real estate leasing business. The company was founded by Hisaichi Goto in April 1952 and is headquartered in Nagoya, Japan.

The Japan Securities Dealers Association operates as its name suggests, serving as an association for securities dealers in Japan. The non-profit company is based in Tokyo, Japan.

Japan Credit Rating Agency Ltd. is a historic rating institution that provides reliable rating and information services to business corporations, financial corporations, public sectors, structures, finance, sobrine, and international organizations. The private company is based in Tokyo, Japan. The Japanese company also introduces green finance, social finance, and ESG initiatives, including green bonds and social bonds. Founded in 1985, the company offers various services such as bonds, structures, and finance rating and information, as well as evaluation of small and medium-sized enterprises and various financial strengths.

Part of Heiwa Real Estate Co., Ltd., The Tokyo Shoken Building, Inc. engages in office rental and management of halls, meeting rooms, hotels, and parking lots. The company is based in Tokyo, Japan. The Tokyo Shoken Building was acquired by Heiwa Real Estate Co., Ltd. on January 17, 2013 for $80.73 million.

Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan.

Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries.

Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.